-
2025-524313-86-00
Autosomal dominant polycystic kidney and liver disease 4
-
2023-507449-27-00
Chronic kidney disease 6
-
2023-504355-28-00
Healthy volunteers 2
-
2023-505380-36-00
Patients with stage I, II, III hormone-receptor positiv 5
-
2023-508169-34-00
Insomnia (ICD-10 F51.0) 5
-
2024-514496-18-00
Hepatocellular carcinoma, renal cell carcinoma and diff 3
-
2024-519131-42-02
PAIN MANAGEMENT 6
-
2025-523286-23-00
Breast Cancer 9
-
2023-504592-24-00
sexual/ erectile function in women and men after treatm 4
-
2025-525001-21-00
Non-traumatic pain 5
-
2024-519757-11-00
Renal Transplantation, living donor 5
-
2024-520336-14-00
Post-chemotherapy neutropenia with high risk of develop 5
-
2025-524122-18-00
Septic shock 5
-
2024-518698-32-00
Wound healing 1
-
2025-524135-39-00
Healthy volunteer trial 3
-
2026-525179-26-00
Cardiometabolic 1
-
2024-517732-21-00
No medical condition. 2
-
2025-522742-46-00
Chronic Kidney disease 6
-
2024-516001-23-00
superficial arteriovenous malformations 4
-
2024-518774-14-00
Kidney transplant recipients 4
-
2024-516415-24-03
General anesthesia 6
-
2024-519864-42-00
active arthritis, vasculitis, pulmonary sarcoidosis 7
-
2025-521651-22-00
hormone receptor positive, HER2-negative breast cancer 4
-
2024-518795-31-00
Adult patients (> 18 years of age) undergoing palliativ 10